New PI3K-delta Inhibitor Prolongs Survival in ... - CLL Support

CLL Support

22,325 members38,394 posts

New PI3K-delta Inhibitor Prolongs Survival in Chronic Lymphocytic Leukaemia

Cllcanada profile image
CllcanadaTop Poster CURE Hero
2 Replies

Lots of good news...it's ASCO time...

The substantial clinical activity of idelalisib that we observed justifies its further clinical development in CLL,” said Jennifer R. Brown, MD, PhD, director of the Chronic Lymphocytic Leukemia center at Dana-Farber Cancer Institute in Massachusetts and lead author of the study.

onclive.com/conference-cove...

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
scottyjean profile image
scottyjean

My husband has been involved in the trial of this drug combined with Rituximab. He has been involved with the trial since the 11th December 2012. His improvement was noticeable within a few weeks of starting the trial and has continued to improve. His counts are now all normal and his lymph nodes have reduced by 75% and his spleen has reduced in size. It was a blind trial so we still do not know whether he had the placebo or the drug but the results would suggest that he had the drug. He will continue to receive the placebo or the drug twice a day and he will be monitored on a six weekly basis. If his condition deteriorates then we will find out whether he has had the drug or the placebo. If he has received the placebo then he will be given the drug, alternatively if he has received the drug then they will increase the dosage. We are enjoying the current improvement and hope that it will continue.

jangreen profile image
jangreen

Hi the more treatments/drugs the better.

You may also like...

Interesting recently published overview of Chronic Lymphocytic Leukaemia and Hairy-Cell Leukaemia

cancernetwork.com/cancer-management/chronic-lymphocytic-leukemia-and-hairy-cell-leukemia?GUID=E5F35D

Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia

eeding-of-richter-transformation-in-chronic-lymphocytic-leukemia-could-lead-to-new-strategies-and-th

Revolution of Chronic Lymphocytic LeukemiaTherapy: the Chemo-Free Treatment Paradigm

gold standard of care for patients with chronic lymphocytic leukemia (CLL). Here we give an...

End of suspense! Here is Dr. Koffman's ASCO 2020 \"Top Pick\" #1!

CLL Society's ASCO 2020 Conference Coverage. End of suspense! Here is Dr. Koffman's ASCO Top Pick...

Early Intervention in Asymptomatic Chronic Lymphocytic Leukemia

/early-intervention-in-asymptomatic-chronic-lymphocytic-leukemia/